{"log_id": 4189871024225840436, "direction": 0, "words_result_num": 52, "words_result": [{"probability": {"variance": 0.01344, "average": 0.956314, "min": 0.608664}, "location": {"width": 113, "top": 201, "height": 24, "left": 224}, "words": "分子量:807.88"}, {"probability": {"variance": 0.033569, "average": 0.878928, "min": 0.43074}, "location": {"width": 312, "top": 219, "height": 34, "left": 223}, "words": "本品铺料为20%酸溶液和聚山梨酯-80"}, {"probability": {"variance": 0.011399, "average": 0.915313, "min": 0.736909}, "location": {"width": 88, "top": 257, "height": 24, "left": 195}, "words": "【性状】"}, {"probability": {"variance": 0.000196, "average": 0.991543, "min": 0.942006}, "location": {"width": 274, "top": 275, "height": 33, "left": 228}, "words": "本品为淡黄色至黄色澄明的黏稠液体"}, {"probability": {"variance": 0.000112, "average": 0.98966, "min": 0.970869}, "location": {"width": 91, "top": 313, "height": 22, "left": 197}, "words": "【适应症】"}, {"probability": {"variance": 2e-06, "average": 0.99895, "min": 0.996866}, "location": {"width": 53, "top": 342, "height": 20, "left": 193}, "words": "乳腺癌"}, {"probability": {"variance": 0.00525, "average": 0.969084, "min": 0.670897}, "location": {"width": 327, "top": 354, "height": 38, "left": 224}, "words": "L.适用于局部晚期或转移性乳腺癌的治疗"}, {"probability": {"variance": 0.007167, "average": 0.96625, "min": 0.498615}, "location": {"width": 852, "top": 361, "height": 57, "left": 225}, "words": "2.多西他赛联含曲妥珠单抗用于HER2基因过度表达的转移性乳腺癌患者的治疗:此类患者先期未接受过转移性乳"}, {"probability": {"variance": 1e-06, "average": 0.998949, "min": 0.996544}, "location": {"width": 104, "top": 419, "height": 21, "left": 263}, "words": "腺癌症的化疗"}, {"probability": {"variance": 0.005472, "average": 0.97403, "min": 0.577054}, "location": {"width": 568, "top": 424, "height": 47, "left": 263}, "words": "多西他赛联合阿霉素及环磷酰胺用于淋巴结阳性的乳腺癌患者的术后辅助化疗"}, {"probability": {"variance": 0.000312, "average": 0.986844, "min": 0.949822}, "location": {"width": 103, "top": 474, "height": 23, "left": 198}, "words": "非小细胞肺癌"}, {"probability": {"variance": 0.002042, "average": 0.983887, "min": 0.777954}, "location": {"width": 609, "top": 478, "height": 47, "left": 230}, "words": "适用于局部晚期或转移性非小细胞肺癌的治疗,即使是在以顺铂为主的化疗失败后"}, {"probability": {"variance": 1e-05, "average": 0.997176, "min": 0.992057}, "location": {"width": 69, "top": 530, "height": 20, "left": 200}, "words": "前列腺癌"}, {"probability": {"variance": 4.9e-05, "average": 0.996688, "min": 0.963403}, "location": {"width": 509, "top": 535, "height": 43, "left": 233}, "words": "多西他赛联合强的松或强的松龙用于治疗激素难治性转移性前列腺癌"}, {"probability": {"variance": 0.002977, "average": 0.967497, "min": 0.872993}, "location": {"width": 93, "top": 582, "height": 22, "left": 205}, "words": "【规格】"}, {"probability": {"variance": 0.009063, "average": 0.959222, "min": 0.663052}, "location": {"width": 165, "top": 606, "height": 23, "left": 235}, "words": "()多西他赛注射液:0"}, {"probability": {"variance": 0.000298, "average": 0.990031, "min": 0.9306}, "location": {"width": 202, "top": 593, "height": 28, "left": 489}, "words": "多西他赛注射液溶剂:1.5m"}, {"probability": {"variance": 0.000465, "average": 0.990358, "min": 0.923974}, "location": {"width": 164, "top": 633, "height": 23, "left": 236}, "words": "2)多西他赛注射液:1"}, {"probability": {"variance": 0.007433, "average": 0.952145, "min": 0.693078}, "location": {"width": 210, "top": 618, "height": 32, "left": 488}, "words": "多西他赛注射液溶剂:4.5ml"}, {"probability": {"variance": 0.000266, "average": 0.990841, "min": 0.949815}, "location": {"width": 140, "top": 660, "height": 23, "left": 235}, "words": "3)多西他赛注射液"}, {"probability": {"variance": 0.000903, "average": 0.984769, "min": 0.898164}, "location": {"width": 158, "top": 649, "height": 29, "left": 489}, "words": "多西他赛注射液溶剂:"}, {"probability": {"variance": 0.003587, "average": 0.968319, "min": 0.834534}, "location": {"width": 93, "top": 692, "height": 22, "left": 208}, "words": "【用法用量】"}, {"probability": {"variance": 0.000881, "average": 0.98709, "min": 0.889883}, "location": {"width": 205, "top": 712, "height": 31, "left": 237}, "words": "多西他赛只能用于静脉滴注"}, {"probability": {"variance": 1e-06, "average": 0.99858, "min": 0.997302}, "location": {"width": 71, "top": 748, "height": 24, "left": 206}, "words": "推荐剂量"}, {"probability": {"variance": 0.000395, "average": 0.985621, "min": 0.957531}, "location": {"width": 47, "top": 780, "height": 22, "left": 210}, "words": "一般性"}, {"probability": {"variance": 0.006462, "average": 0.974257, "min": 0.51965}, "location": {"width": 840, "top": 778, "height": 57, "left": 243}, "words": "多西他赛的推荐剂量为每3周75mg/m2,滴注1小时。为减轻体液涨留,除有禁忌外,所有病人在接受多西他赛治"}, {"probability": {"variance": 0.002865, "average": 0.979609, "min": 0.624715}, "location": {"width": 879, "top": 809, "height": 58, "left": 207}, "words": "疗前均必须预服药物,此类药物只能包括口服糖皮质激素类,如地塞米松在多西他赛滴注1天前服用,每日16ng(例如"}, {"probability": {"variance": 0.01255, "average": 0.960669, "min": 0.389968}, "location": {"width": 876, "top": 840, "height": 59, "left": 208}, "words": "每日2次,每次8mg)持续3天。只有医生才能修改治疗方案。多西他赛不能用于中性粒细胞数目低于1500/m3的病"}, {"probability": {"variance": 0.002009, "average": 0.985321, "min": 0.705208}, "location": {"width": 741, "top": 877, "height": 51, "left": 211}, "words": "人。多西他赛治疗期间,如果病人发生发热性中性粒细胞减少且中性粒细胞数目持续1周以上低于50"}, {"probability": {"variance": 3.2e-05, "average": 0.996069, "min": 0.985136}, "location": {"width": 84, "top": 874, "height": 21, "left": 1010}, "words": "出现严重或"}, {"probability": {"variance": 0.000106, "average": 0.99262, "min": 0.956596}, "location": {"width": 461, "top": 919, "height": 42, "left": 212}, "words": "蓄积性皮肤反应或外周神经症状,多西他赛的剂量应酌情递减"}, {"probability": {"variance": 8.5e-05, "average": 0.995651, "min": 0.947606}, "location": {"width": 840, "top": 935, "height": 57, "left": 244}, "words": "治疗前列腺癌时,同时给予强的松或强的松龙,推荐化疗前用药剂量及方案为:患者在接受多西他赛治疗前12小时"}, {"probability": {"variance": 0.009673, "average": 0.973525, "min": 0.484467}, "location": {"width": 386, "top": 987, "height": 38, "left": 210}, "words": "3小时及1小时,口服地塞米松8mg(见[注意事项)。"}, {"probability": {"variance": 0.009227, "average": 0.966317, "min": 0.472853}, "location": {"width": 555, "top": 1010, "height": 46, "left": 249}, "words": "预防性使用粒细胞集落刺激因子(G-CSF)以减轻药物血液毒性发生的风险"}, {"probability": {"variance": 0.000461, "average": 0.984752, "min": 0.954402}, "location": {"width": 54, "top": 1065, "height": 22, "left": 215}, "words": "乳腺癌"}, {"probability": {"variance": 0.000571, "average": 0.989505, "min": 0.872729}, "location": {"width": 715, "top": 1069, "height": 51, "left": 249}, "words": "在可以手术的淋巴结阳性的乳腺癌辅助化疗中,推荐剂量为:给予阿霉素50mg/m2及环磷酰胺50"}, {"probability": {"variance": 0.007503, "average": 0.94579, "min": 0.795993}, "location": {"width": 65, "top": 1064, "height": 23, "left": 1025}, "words": "1小时后"}, {"probability": {"variance": 0.003312, "average": 0.971877, "min": 0.698057}, "location": {"width": 543, "top": 1108, "height": 46, "left": 215}, "words": "给予多西他赛75mg/m2,每3周1次,进行6个周期(见治疗中调整剂量)"}, {"probability": {"variance": 0.000348, "average": 0.992239, "min": 0.897281}, "location": {"width": 542, "top": 1139, "height": 44, "left": 254}, "words": "治疗局部晚期或转移性乳腺癌患者时,多西他赛单一用药的推荐剂量为10"}, {"probability": {"variance": 0.000279, "average": 0.990676, "min": 0.939584}, "location": {"width": 175, "top": 1131, "height": 27, "left": 879}, "words": "线用药时,多西他赛75"}, {"probability": {"variance": 0.007546, "average": 0.95664, "min": 0.679196}, "location": {"width": 287, "top": 1182, "height": 36, "left": 216}, "words": "联合阿霉素50mg/m2(见安全处置建议)"}, {"probability": {"variance": 0.003271, "average": 0.980166, "min": 0.631307}, "location": {"width": 843, "top": 1189, "height": 59, "left": 255}, "words": "与曲珠单抗联合用药时,多西他赛推荐剂量为:100mg/m2,每3周1次,曲珠单抗每周1次。在一项关键临床"}, {"probability": {"variance": 0.002974, "average": 0.977153, "min": 0.669416}, "location": {"width": 878, "top": 1221, "height": 61, "left": 227}, "words": "开究中,多西他赛首次静脉给药应于曲妥珠单抗第1次用药后1天。如果患者对前次曲妥珠单抗剂量耐受良好,多西他赛"}, {"probability": {"variance": 0.006313, "average": 0.974592, "min": 0.547021}, "location": {"width": 682, "top": 1262, "height": 51, "left": 220}, "words": "以后的用药应紧随曲妥珠单抗静脉输注之后给药。曲要珠单抗的用法及用量见其产品说明书"}, {"probability": {"variance": 0.009068, "average": 0.964689, "min": 0.467225}, "location": {"width": 838, "top": 1318, "height": 61, "left": 256}, "words": "治疗非小细胞肺癌时,对于前期未经治疗的患者治疗非小细胞肺癌推荐剂量为多西他赛75mg/m2,并立即给予顺铂"}, {"probability": {"variance": 0.000165, "average": 0.988334, "min": 0.964236}, "location": {"width": 104, "top": 1320, "height": 23, "left": 222}, "words": "非小细胞肺癌"}, {"probability": {"variance": 0.010139, "average": 0.966934, "min": 0.402526}, "location": {"width": 736, "top": 1358, "height": 53, "left": 224}, "words": "7mg/m2静脉输注30-60分钟对于前期铂类治疗失败的患者,多西他赛推荐剂量为单一用药75mg/"}, {"probability": {"variance": 0.000834, "average": 0.98254, "min": 0.932539}, "location": {"width": 72, "top": 1418, "height": 22, "left": 224}, "words": "前列腺癌"}, {"probability": {"variance": 0.000301, "average": 0.992195, "min": 0.906549}, "location": {"width": 721, "top": 1421, "height": 52, "left": 257}, "words": "推荐剂量为多西他赛75mg/m2,每3周一疗程,连续口服强的松或强的松龙每日2次,每次5mg"}, {"probability": {"variance": 7.9e-05, "average": 0.993258, "min": 0.973198}, "location": {"width": 121, "top": 1480, "height": 24, "left": 227}, "words": "治疗中调整剂量"}, {"probability": {"variance": 0, "average": 0.999336, "min": 0.999071}, "location": {"width": 41, "top": 1515, "height": 21, "left": 243}, "words": "般性"}, {"probability": {"variance": 0.003224, "average": 0.969086, "min": 0.737564}, "location": {"width": 378, "top": 1530, "height": 39, "left": 263}, "words": "多西他赛应用于中性粒细胞计数≥1500/m3的患者"}], "language": 3}